Bariatric operations for management of obesity
Candidates for a bariatric surgical procedure include
● Adults with a BMI ≥40 kg/m2 without comorbid illness
● Adults with a BMI 35.0 to 39.9 kg/m2 with at least one serious comorbidity, including but not limited to:
•Type 2 diabetes [47,48]
•Obstructive sleep apnea (OSA)
•Hypertension
•Hyperlipidemia
•Obesity-hypoventilation syndrome (OHS)
•Pickwickian syndrome (combination of OSA and OHS)
•Nonalcoholic fatty liver disease (NAFLD)
•Nonalcoholic steatohepatitis (NASH)
•Pseudotumor cerebri
•Gastroesophageal reflux disease
•Asthma
•Venous stasis disease
•Severe urinary incontinence
•Debilitating arthritis
•Impaired quality of life
•Disqualification from other surgeries as a result of obesity
(ie, surgeries for osteoarthritic disease, ventral hernias, or stress incontinence)
● Adults with BMI between 30.0 to 34.9 kg/m2 AND one of the following comorbid conditions,
although there is no long-term evidence of benefit to support routinely performing a bariatric operation.
•Uncontrollable type 2 diabetes
•Metabolic syndrome
REF. UpToDate 2018.01.15
'내분비내과 > 비만' 카테고리의 다른 글
비만치료제 삭센다의 흔한 이상 반응 (0) | 2021.06.10 |
---|---|
[비만치료제] 콘트라브 (부프로피온-날트렉손), Contrave (bupropion-naltrexone) (0) | 2021.01.29 |
[비만치료제] GLP-1 수용체 효능제, 삭센다 (0) | 2021.01.29 |
[비만치료제] 오르리스타트, Orlistat (0) | 2021.01.29 |
삭센다, 설사, Saxenda, diarrhea (0) | 2020.11.03 |